Thomas A. Raffin's most recent trade in Akoya Biosciences Inc was a trade of 15,937,535 Common Stock done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 15,937,535 | 0 | - | - | Common Stock | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 1,737,712 | 0 | - | - | Common Stock | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 234,592 | 0 | - | - | Common Stock | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 56,322 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 30,549 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 16,860 | 0 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,328 | 3,328 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 1,803,373 | 15,937,535 | - | 5 | 9,016,865 | Common Stock |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 196,627 | 1,737,712 | - | 5 | 983,135 | Common Stock |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 234,592 | - | 5 | 100,000 | Common Stock |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 3,345 | 3,345 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 8.46 per share. | 25 Aug 2022 | 1,150 | 9,406 (0%) | 0% | 8.5 | 9,729 | Common Stock |
| Akoya Biosciences Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 3,431 | 3,431 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 2,910 | 2,910 | - | - | Stock Option (Right to Buy) | |
| Lumos Pharma Inc | Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 367 | 8,256 (0%) | 0% | 0 | Common Stock |